[Therapeutic indications targeting etiology. (With the exception of primary progressive forms)]
- PMID: 11787332
[Therapeutic indications targeting etiology. (With the exception of primary progressive forms)]
Abstract
On the subject of the treatment of Multiple Sclerosis, JM Charcot stated in 1877 that "the time has not yet come when such a subject can be seriously considered". Fortunately such point of view is no more up to date. This chapter will review the available treatment for relapsing-remitting and secondary progressive Multiple Sclerosis. The immunosuppressive drugs and steroids have been used for many years. Immunomodulation appeared more recently. A review of the evidence on the use of those drugs will be performed.
Similar articles
-
[Immunomodulatory therapy in multiple sclerosis].Ideggyogy Sz. 2004 Nov 20;57(11-12):401-16. Ideggyogy Sz. 2004. PMID: 15662768 Review. Hungarian.
-
[New immunomodulator for multiple sclerosis patients. 30% fewer relapse rates].MMW Fortschr Med. 2002 May 6;Suppl 2:88. MMW Fortschr Med. 2002. PMID: 12070870 German. No abstract available.
-
[Therapeutic indications targeting etiology of progressive multiple sclerosis].Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):1001-7. Rev Neurol (Paris). 2001. PMID: 11787330 Review. French.
-
Multiple sclerosis.Clin Evid. 2002 Jun;(7):1195-207. Clin Evid. 2002. Update in: Clin Evid. 2003 Jun;(9):1459-73. PMID: 12230737 Updated. Review. No abstract available.
-
Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis.Eur Neurol. 2000;43(3):186-7. doi: 10.1159/000008163. Eur Neurol. 2000. PMID: 10765063 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical